Concepts (213)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Psychotic Disorders | 28 | 2023 | 3046 | 5.380 |
Why?
|
| Choroid Plexus | 7 | 2023 | 231 | 3.140 |
Why?
|
| Schizophrenia | 22 | 2023 | 6882 | 2.920 |
Why?
|
| Bipolar Disorder | 13 | 2023 | 5027 | 1.250 |
Why?
|
| Retinal Vessels | 3 | 2022 | 772 | 1.070 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 2 | 2016 | 552 | 0.880 |
Why?
|
| Psychiatry | 2 | 2023 | 1695 | 0.780 |
Why?
|
| Antipsychotic Agents | 4 | 2021 | 3057 | 0.770 |
Why?
|
| Tomography, Optical Coherence | 4 | 2022 | 2657 | 0.750 |
Why?
|
| Nitric Oxide Synthase Type II | 4 | 2017 | 534 | 0.720 |
Why?
|
| Hallucinations | 2 | 2022 | 360 | 0.720 |
Why?
|
| Neurosciences | 1 | 2023 | 348 | 0.670 |
Why?
|
| Microvessels | 2 | 2022 | 544 | 0.640 |
Why?
|
| Clozapine | 1 | 2021 | 498 | 0.630 |
Why?
|
| Endophenotypes | 1 | 2020 | 250 | 0.630 |
Why?
|
| Ophthalmology | 1 | 2023 | 508 | 0.600 |
Why?
|
| Cell Respiration | 1 | 2017 | 201 | 0.570 |
Why?
|
| Neurologic Examination | 1 | 2019 | 930 | 0.540 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2023 | 1736 | 0.500 |
Why?
|
| Brain Diseases | 1 | 2023 | 1563 | 0.480 |
Why?
|
| Brain | 19 | 2023 | 26385 | 0.470 |
Why?
|
| HSP20 Heat-Shock Proteins | 4 | 2015 | 5 | 0.460 |
Why?
|
| Tourette Syndrome | 1 | 2016 | 379 | 0.460 |
Why?
|
| Cognition | 6 | 2023 | 6770 | 0.420 |
Why?
|
| Retina | 2 | 2020 | 2616 | 0.410 |
Why?
|
| Schizophrenic Psychology | 1 | 2019 | 1678 | 0.410 |
Why?
|
| Frontal Lobe | 1 | 2018 | 1406 | 0.410 |
Why?
|
| Temporal Lobe | 1 | 2018 | 1670 | 0.380 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2018 | 3508 | 0.360 |
Why?
|
| Single-Blind Method | 2 | 2023 | 1590 | 0.350 |
Why?
|
| Myocytes, Cardiac | 4 | 2017 | 1637 | 0.350 |
Why?
|
| Cell Survival | 2 | 2017 | 5882 | 0.340 |
Why?
|
| Adenosine Triphosphatases | 1 | 2013 | 839 | 0.330 |
Why?
|
| Memory, Short-Term | 3 | 2023 | 975 | 0.320 |
Why?
|
| Inflammation | 6 | 2023 | 10638 | 0.320 |
Why?
|
| Cross-Over Studies | 2 | 2023 | 2029 | 0.310 |
Why?
|
| Myocardium | 3 | 2017 | 4776 | 0.310 |
Why?
|
| Muscle Proteins | 4 | 2015 | 1159 | 0.300 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2016 | 1444 | 0.290 |
Why?
|
| Interferon-gamma | 1 | 2015 | 3206 | 0.290 |
Why?
|
| Mitochondria, Heart | 3 | 2015 | 247 | 0.290 |
Why?
|
| Humans | 48 | 2023 | 744343 | 0.280 |
Why?
|
| Magnetic Resonance Imaging | 12 | 2023 | 35421 | 0.240 |
Why?
|
| Mitochondria | 1 | 2017 | 3520 | 0.240 |
Why?
|
| Mental Disorders | 1 | 2023 | 6600 | 0.230 |
Why?
|
| Philosophy | 1 | 2023 | 66 | 0.230 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2023 | 141 | 0.230 |
Why?
|
| Visual Cortex | 2 | 2022 | 1149 | 0.220 |
Why?
|
| Heat-Shock Proteins | 5 | 2015 | 822 | 0.220 |
Why?
|
| Blood-Brain Barrier | 3 | 2023 | 1017 | 0.210 |
Why?
|
| Cognition Disorders | 1 | 2016 | 4043 | 0.210 |
Why?
|
| Neuroanatomy | 1 | 2022 | 66 | 0.210 |
Why?
|
| Cell Cycle Proteins | 1 | 2013 | 3462 | 0.200 |
Why?
|
| Evoked Potentials, Visual | 1 | 2023 | 427 | 0.190 |
Why?
|
| Pilot Projects | 2 | 2023 | 8324 | 0.180 |
Why?
|
| Endothelial Cells | 2 | 2023 | 3479 | 0.170 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2020 | 17446 | 0.170 |
Why?
|
| Cells, Cultured | 7 | 2023 | 19229 | 0.160 |
Why?
|
| Phenotype | 5 | 2023 | 16365 | 0.160 |
Why?
|
| Paresis | 1 | 2019 | 179 | 0.150 |
Why?
|
| DiGeorge Syndrome | 1 | 2019 | 177 | 0.150 |
Why?
|
| Family | 2 | 2020 | 3147 | 0.150 |
Why?
|
| Organ Size | 2 | 2019 | 2252 | 0.140 |
Why?
|
| Gene Deletion | 2 | 2017 | 2751 | 0.140 |
Why?
|
| Molecular Chaperones | 4 | 2015 | 742 | 0.140 |
Why?
|
| Cannabis | 1 | 2023 | 439 | 0.140 |
Why?
|
| Longitudinal Studies | 3 | 2023 | 13989 | 0.140 |
Why?
|
| Angiography | 1 | 2022 | 1639 | 0.140 |
Why?
|
| Adenosine Diphosphate | 1 | 2017 | 425 | 0.140 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2017 | 154 | 0.140 |
Why?
|
| Cryopreservation | 1 | 2020 | 670 | 0.130 |
Why?
|
| Conversion Disorder | 1 | 2019 | 205 | 0.130 |
Why?
|
| Outpatients | 1 | 2023 | 1486 | 0.130 |
Why?
|
| Visual Pathways | 1 | 2020 | 565 | 0.130 |
Why?
|
| Complement System Proteins | 1 | 2019 | 795 | 0.130 |
Why?
|
| Gyrus Cinguli | 1 | 2021 | 1091 | 0.130 |
Why?
|
| Thalamus | 2 | 2021 | 1023 | 0.130 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2023 | 4420 | 0.130 |
Why?
|
| Cardiovascular Agents | 1 | 2021 | 850 | 0.130 |
Why?
|
| Young Adult | 7 | 2022 | 56430 | 0.130 |
Why?
|
| Male | 18 | 2022 | 350118 | 0.120 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2017 | 476 | 0.120 |
Why?
|
| Amygdala | 2 | 2021 | 1315 | 0.110 |
Why?
|
| Oxygen Consumption | 2 | 2017 | 1869 | 0.110 |
Why?
|
| Neuropsychological Tests | 3 | 2023 | 6993 | 0.110 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2022 | 1432 | 0.110 |
Why?
|
| Hippocampus | 3 | 2023 | 3675 | 0.100 |
Why?
|
| Adult | 9 | 2022 | 214055 | 0.100 |
Why?
|
| NF-kappa B | 4 | 2013 | 2499 | 0.100 |
Why?
|
| Ischemic Preconditioning, Myocardial | 1 | 2011 | 67 | 0.100 |
Why?
|
| Female | 13 | 2022 | 380194 | 0.100 |
Why?
|
| Genetic Testing | 1 | 2023 | 3444 | 0.090 |
Why?
|
| Interleukin-10 | 1 | 2015 | 1200 | 0.090 |
Why?
|
| Statistics as Topic | 1 | 2016 | 2373 | 0.090 |
Why?
|
| Mice, Transgenic | 3 | 2017 | 9734 | 0.090 |
Why?
|
| Cardiomegaly | 2 | 2011 | 620 | 0.090 |
Why?
|
| Continuity of Patient Care | 1 | 2016 | 1049 | 0.080 |
Why?
|
| Adolescent | 6 | 2020 | 85781 | 0.080 |
Why?
|
| Reproducibility of Results | 2 | 2023 | 19905 | 0.080 |
Why?
|
| Isoenzymes | 1 | 2013 | 1726 | 0.080 |
Why?
|
| Brain Mapping | 1 | 2023 | 6669 | 0.080 |
Why?
|
| STAT3 Transcription Factor | 1 | 2011 | 873 | 0.070 |
Why?
|
| Cost-Benefit Analysis | 1 | 2019 | 5391 | 0.070 |
Why?
|
| Oxidative Phosphorylation | 3 | 2015 | 481 | 0.070 |
Why?
|
| Linear Models | 1 | 2016 | 5952 | 0.070 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2016 | 6038 | 0.070 |
Why?
|
| Calcitriol | 1 | 2007 | 298 | 0.070 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2015 | 8301 | 0.070 |
Why?
|
| Acute Disease | 1 | 2015 | 7149 | 0.060 |
Why?
|
| Receptors, Calcitriol | 1 | 2007 | 350 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2013 | 2503 | 0.060 |
Why?
|
| Logistic Models | 1 | 2019 | 13408 | 0.060 |
Why?
|
| Protease Inhibitors | 1 | 2008 | 791 | 0.060 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 8642 | 0.060 |
Why?
|
| Gene Expression | 1 | 2017 | 7799 | 0.060 |
Why?
|
| Mice | 7 | 2017 | 81183 | 0.060 |
Why?
|
| Cerebral Cortex | 1 | 2019 | 5708 | 0.060 |
Why?
|
| Behavior Control | 1 | 2023 | 45 | 0.060 |
Why?
|
| Nitric Oxide | 1 | 2012 | 2132 | 0.060 |
Why?
|
| Genetic Variation | 1 | 2018 | 6544 | 0.060 |
Why?
|
| Rats | 3 | 2015 | 24260 | 0.050 |
Why?
|
| Hypertension | 1 | 2022 | 8480 | 0.050 |
Why?
|
| Fovea Centralis | 1 | 2022 | 119 | 0.050 |
Why?
|
| Coronary Artery Disease | 1 | 2021 | 6487 | 0.050 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2019 | 4266 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2019 | 21746 | 0.050 |
Why?
|
| Ventricular Remodeling | 1 | 2008 | 1224 | 0.050 |
Why?
|
| Animals | 8 | 2022 | 168757 | 0.050 |
Why?
|
| Models, Biological | 1 | 2017 | 9583 | 0.050 |
Why?
|
| Collagen Type IV | 1 | 2020 | 140 | 0.050 |
Why?
|
| Myocardial Ischemia | 1 | 2011 | 2148 | 0.050 |
Why?
|
| Schizophrenia, Paranoid | 1 | 2020 | 104 | 0.040 |
Why?
|
| Basement Membrane | 1 | 2020 | 356 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2016 | 8949 | 0.040 |
Why?
|
| Cerebrospinal Fluid | 1 | 2022 | 534 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 15519 | 0.040 |
Why?
|
| Prognosis | 1 | 2019 | 29063 | 0.040 |
Why?
|
| Spin Labels | 1 | 2020 | 332 | 0.040 |
Why?
|
| Leukemia | 1 | 2007 | 1511 | 0.040 |
Why?
|
| Heart | 1 | 2012 | 4467 | 0.040 |
Why?
|
| Fluorescein Angiography | 1 | 2022 | 940 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 39050 | 0.040 |
Why?
|
| Monocytes | 1 | 2007 | 2596 | 0.040 |
Why?
|
| Fibronectins | 1 | 2020 | 726 | 0.040 |
Why?
|
| Coculture Techniques | 1 | 2020 | 1341 | 0.040 |
Why?
|
| Electric Impedance | 1 | 2020 | 729 | 0.040 |
Why?
|
| Nerve Fibers | 1 | 2020 | 687 | 0.030 |
Why?
|
| Cross-Sectional Studies | 3 | 2023 | 25043 | 0.030 |
Why?
|
| Motion Perception | 1 | 2020 | 408 | 0.030 |
Why?
|
| Heart Failure | 2 | 2011 | 10900 | 0.030 |
Why?
|
| Ventricular Function, Left | 1 | 2008 | 3670 | 0.030 |
Why?
|
| Physical Therapy Modalities | 1 | 2019 | 550 | 0.030 |
Why?
|
| Back Pain | 1 | 2019 | 545 | 0.030 |
Why?
|
| Membrane Transport Proteins | 1 | 2020 | 1028 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2022 | 1357 | 0.030 |
Why?
|
| Mitochondrial Membranes | 1 | 2015 | 175 | 0.030 |
Why?
|
| Depression | 2 | 2023 | 7766 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2020 | 1351 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2015 | 40561 | 0.030 |
Why?
|
| Middle Aged | 3 | 2022 | 213383 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2020 | 1741 | 0.030 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2012 | 255 | 0.030 |
Why?
|
| Child | 4 | 2023 | 77709 | 0.030 |
Why?
|
| Nitroarginine | 1 | 2011 | 66 | 0.020 |
Why?
|
| Headache | 1 | 2019 | 1226 | 0.020 |
Why?
|
| Circadian Rhythm | 1 | 2022 | 2624 | 0.020 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2020 | 2305 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2022 | 3778 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 2020 | 2731 | 0.020 |
Why?
|
| Psychotherapy | 1 | 2019 | 1643 | 0.020 |
Why?
|
| Protein Transport | 1 | 2015 | 1988 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2019 | 2278 | 0.020 |
Why?
|
| Transgenes | 1 | 2012 | 1009 | 0.020 |
Why?
|
| Executive Function | 1 | 2017 | 1364 | 0.020 |
Why?
|
| Collagen Type III | 1 | 2008 | 90 | 0.020 |
Why?
|
| Cell Differentiation | 2 | 2020 | 11483 | 0.020 |
Why?
|
| Ligation | 1 | 2008 | 453 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2012 | 2008 | 0.020 |
Why?
|
| Attention | 1 | 2017 | 2400 | 0.020 |
Why?
|
| HL-60 Cells | 1 | 2007 | 365 | 0.020 |
Why?
|
| Indicators and Reagents | 1 | 2007 | 462 | 0.020 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2008 | 472 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2011 | 1549 | 0.020 |
Why?
|
| Sleep | 1 | 2021 | 4623 | 0.020 |
Why?
|
| Collagen Type I | 1 | 2008 | 592 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2020 | 10481 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2012 | 2077 | 0.020 |
Why?
|
| Ischemia | 1 | 2012 | 1907 | 0.010 |
Why?
|
| Myocardial Contraction | 1 | 2008 | 1585 | 0.010 |
Why?
|
| Oligopeptides | 1 | 2008 | 1189 | 0.010 |
Why?
|
| Collagen | 1 | 2011 | 2689 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2011 | 2969 | 0.010 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2008 | 1338 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2007 | 2187 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2011 | 3200 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2007 | 3129 | 0.010 |
Why?
|
| Swine | 1 | 2011 | 5917 | 0.010 |
Why?
|
| Aorta | 1 | 2008 | 2061 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 4751 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 2011 | 3107 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2007 | 2967 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2007 | 5456 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2021 | 53288 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2011 | 14557 | 0.010 |
Why?
|
| Stroke Volume | 1 | 2008 | 5007 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 9438 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2008 | 13033 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2007 | 7722 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2008 | 8554 | 0.010 |
Why?
|
| Apoptosis | 1 | 2008 | 9727 | 0.010 |
Why?
|
| Risk Factors | 1 | 2017 | 72290 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2008 | 18029 | 0.010 |
Why?
|
| Time Factors | 1 | 2008 | 40075 | 0.000 |
Why?
|
Concepts
(213)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(30)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_